Italian guidelines on thrombolysis indications in ischemic stroke have been revised after the IST-3 trial and Cochrane review

Internal and Emergency Medicine

Volumn 9, Issue 7, 2014, Pages 823-824

  Paciaroni, Maurizio ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC THERAPY; HUMAN; LITERATURE; PRACTICE GUIDELINE; STROKE;

HUMANS; PRACTICE GUIDELINES AS TOPIC; REVIEW LITERATURE AS TOPIC; STROKE; THROMBOLYTIC THERAPY;

EID: 84918837006     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-014-1109-0     Document Type: Letter

References (5)

1. Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL, Cohen G (2012) Recombinant tissue plasminogen activator for acute ischemic stroke: an updated systematic review and meta-analysis. Lancet 379:2364–2372
2. The third international stroke trial (2012) (IST-3) collaborative group. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischemic stroke (IST-3): a randomized controlled trial. Lancet 379:2352–2363
3. Ricci S, Cenciarelli S, Mazzoli T (2013) Italian guidelines on thrombolysis indications in ischemic stroke have been revised after IST-3 trial and Cochrane Review: pros. Intern Emerg Med 8:653–654
4. Costantino G, Podda GM, Bonzi M, Sbrojavacca R (2013) Italian guidelines on thrombolysis indications in ischemic stroke have been revised after IST-3 trial and Cochrane Review: cons. Intern Emerg Med 8:651–652
5. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW Jr, Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H (2013) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44:870–947